{"content":"<li class=\"n-box-item date-title\" data-end=\"1420779599\" data-start=\"1420693200\" data-txt=\"Sunday, December 22, 2019\">Thursday, January  8, 2015</li><li class=\"n-box-item sa-box-item\" data-id=\"2213855\" data-ts=\"1420760071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBLK\" target=\"_blank\">SBLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213855-star-bulk-carriers-files-for-200m-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Star Bulk Carriers files for $200M public offering</a></h4><ul>\n<li>Star Bulk Carriers (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SBLK\" title=\"Star Bulk Carriers Corp.\">SBLK</a>) <font color=\"red\">-18%</font> AH after filing to <a href=\"https://www.sec.gov/Archives/edgar/data/1386716/000156761915000008/s000695x1_424b5.htm\" target=\"_blank\">sell $200M in common stock</a>, with a 30-day underwriters option to purchase additional shares.</li>\n<li>SBLK says it plans to use the proceeds for its new building program and general corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213855\" data-linked=\"Star Bulk Carriers files for $200M public offering\" data-tweet=\"$SBLK - Star Bulk Carriers files for $200M public offering https://seekingalpha.com/news/2213855-star-bulk-carriers-files-for-200m-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/2213855-star-bulk-carriers-files-for-200m-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213825\" data-ts=\"1420759189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RT\" target=\"_blank\">RT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213825-ruby-tuesday-minus-10-percent-after-cutting-full-year-sales-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruby Tuesday -10% after cutting full-year sales guidance</a></h4><ul>\n<li>Ruby Tuesday (NYSE:<a href=\"https://seekingalpha.com/symbol/RT\" title=\"Ruby Tuesday, Inc.\">RT</a>) <font color=\"red\">-9.8%</font> AH after posting disappointing <a href=\"https://seekingalpha.com/news/2213445-ruby-tuesday-eps-in-line-misses-on-revenue\" target=\"_blank\">Q2 results</a> and lowering its full-year sales guidance.</li>\n<li>The casual dining chain now expects to sales at restaurants open at least 18 months to come in at a  range of +1% to -1%, compared with its previous estimate for 1%-2% growth; estimates FQ3 same-restaurant sales at -2% to +1%.</li>\n<li>During FQ2, same-restaurant sales fell 1% Y/Y, while same-restaurant guest counts were down 1.3%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213825\" data-linked=\"Ruby Tuesday -10% after cutting full-year sales guidance\" data-tweet=\"$RT - Ruby Tuesday -10% after cutting full-year sales guidance https://seekingalpha.com/news/2213825-ruby-tuesday-minus-10-percent-after-cutting-full-year-sales-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2213825-ruby-tuesday-minus-10-percent-after-cutting-full-year-sales-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213745\" data-ts=\"1420756623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCS\" target=\"_blank\">TCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213745-container-store-minus-8_5-percent-ah-on-sales-miss-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Container Store -8.5% AH on sales miss, soft guidance</a></h4><ul>\n<li>On account of its FQ3 performance and a strong dollar, The Container Store (NYSE:<a href=\"https://seekingalpha.com/symbol/TCS\" title=\"The Container Store Group, Inc.\">TCS</a>) expects FY14 (ends Feb. '14) revenue of $785M-$795M and EPS of $0.41-$0.44 vs. a consensus of 803.3M and $0.43.</li>\n<li>Total comparable store sales were down 3.5% in FQ3, at the low end of guidance for flat to negative low-single digits. Though comps are up 2.7% to date in FQ4, they're expected to be \"flat to slightly negative\" for the whole of FY14.</li>\n<li>Net sales for The Container Store retail business were up 2.9% due to new store openings, while online sales rose 13.2%. Gross margin fell 40 bps to 59.6%, and SG&amp;A spend rose 6% to $93.8M.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2213435-the-container-store-eps-in-line-misses-on-revenue\" target=\"_blank\">FQ3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213745\" data-linked=\"Container Store -8.5% AH on sales miss, soft guidance\" data-tweet=\"$TCS - Container Store -8.5% AH on sales miss, soft guidance https://seekingalpha.com/news/2213745-container-store-minus-8_5-percent-ah-on-sales-miss-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2213745-container-store-minus-8_5-percent-ah-on-sales-miss-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213725\" data-ts=\"1420756526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213725-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hour Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a> <font color='green'>+11.9%</font>. <a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color='green'>+4.9%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a> <font color='green'>+2.6%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/EOPN' title='E2open'>EOPN</a> <font color='red'>-35.9%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-35.2%</font>. <a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a> <font color='red'>-15.2%</font>. <a href='https://seekingalpha.com/symbol/BARL' title='Morgan Stanley S&P 500 Crude Oil Linked ETN'>BARL</a> <font color='red'>-15.1%</font>. <a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color='red'>-15.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213725\" data-linked=\"After Hour Gainers / Losers\" data-tweet=\"$RVNC $HELE $RRTS - After Hour Gainers / Losers https://seekingalpha.com/news/2213725-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2213725-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213705\" data-ts=\"1420755683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213705-five-below-reports-soft-holiday-sales-expects-disappointing-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below reports soft holiday sales, expects disappointing Q4</a></h4><ul>     <li>Five Below (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a>) <font color=\"red\">-15%</font> AH after saying it sees Q4 results coming in below Wall Street expectations, reflecting softness after Black Friday continuing into  Christmas and the post-holiday period.</li>     <li>FIVE now sees Q4 sales in the range of $262M-$263M vs. prior guidance of $262M-$266M and analyst consensus of $265M, and EPS of $0.59-$0.60 vs.its earlier outlook for $0.59-$0.62 and below $0.61 consensus.</li>\n<li>FIVE says same-store sales rose 3.2% Y/Y for the nine weeks of the quarter through Jan. 3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213705\" data-linked=\"Five Below reports soft holiday sales, expects disappointing Q4\" data-tweet=\"$FIVE - Five Below reports soft holiday sales, expects disappointing Q4 https://seekingalpha.com/news/2213705-five-below-reports-soft-holiday-sales-expects-disappointing-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/2213705-five-below-reports-soft-holiday-sales-expects-disappointing-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213685\" data-ts=\"1420754388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBEPQ\" target=\"_blank\">BBEPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213685-qr-energy-unitholders-selling-19_74m-breitburn-energy-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QR Energy unitholders selling 19.74M Breitburn Energy units</a></h4><ul>\n<li>Breitburn Energy Partners (BBEP) <font color=\"red\">-3.7%</font> AH after filing for an <a href=\"https://www.sec.gov/Archives/edgar/data/1357371/000119312515005122/d842064ds3.htm\" target=\"_blank\">offering of ~19.74M common units</a>  representing limited partner interests being sold by selling unitholders who acquired the units via the merger with QR Energy.</li>\n<li>BBEP will receive no proceeds from the sale.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213685\" data-linked=\"QR Energy unitholders selling 19.74M Breitburn Energy units\" data-tweet=\"$BBEPQ - QR Energy unitholders selling 19.74M Breitburn Energy units https://seekingalpha.com/news/2213685-qr-energy-unitholders-selling-19_74m-breitburn-energy-units?source=tweet\" data-url=\"https://seekingalpha.com/news/2213685-qr-energy-unitholders-selling-19_74m-breitburn-energy-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213665\" data-ts=\"1420754322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOPN\" target=\"_blank\">EOPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213665-e2open-down-32_1-percent-ah-on-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E2open down 32.1% AH on weak guidance</a></h4><ul>\n<li>Though it beat FQ3 EPS estimates and only slightly missed on revenue, E2open (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EOPN\" title=\"E2open\">EOPN</a>) has guided for FQ4 revenue of $19.3M-$19.8M and EPS of -$0.20 to -$0.22, below a consensus of $22.7M and -$0.16.</li>\n<li>Much like many enterprise tech companies before it, E2open blames \"recent sales execution challenges.\" The cloud business process software vendor says it has \"taken steps to correct these issues.\"</li>\n<li>Subscription/support revenue rose 15% Y/Y in FQ3 to $16.9M, while professional services revenue fell 8% to $3.9M.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2213475-e2open-beats-by-0_03-misses-on-revenue\" target=\"_blank\">FQ3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213665\" data-linked=\"E2open down 32.1% AH on weak guidance\" data-tweet=\"$EOPN - E2open down 32.1% AH on weak guidance https://seekingalpha.com/news/2213665-e2open-down-32_1-percent-ah-on-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2213665-e2open-down-32_1-percent-ah-on-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213655\" data-ts=\"1420753456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SD\" target=\"_blank\">SD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213655-sandridge-energy-beats-by-0_03\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SandRidge Energy beats by $0.03</a></h4><ul>\n<li>SandRidge Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/SD\" title=\"SandRidge Energy, Inc.\">SD</a>): FQ3 EPS of $0.07 <font color=\"green\">beats by $0.03</font>.</li>\n<li>Revenue of $394.1M (-20.2% Y/Y)</li>\n<li>Shares <font color=\"green\">+7.5%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213655\" data-linked=\"SandRidge Energy beats by $0.03\" data-tweet=\"$SD - SandRidge Energy beats by $0.03 https://seekingalpha.com/news/2213655-sandridge-energy-beats-by-0_03?source=tweet\" data-url=\"https://seekingalpha.com/news/2213655-sandridge-energy-beats-by-0_03\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213645\" data-ts=\"1420753338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213645-bed-bath-and-beyond-minus-6_2-percent-ah-on-revenue-miss-slowing-comps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond -6.2% AH on revenue miss, slowing comps</a></h4><ul>\n<li>Bed Bath &amp; Beyond's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a>) comparable store sales rose 1.7% Y/Y in FQ3, a slowdown from FQ2's 3.4%.</li>\n<li>The retailer continues to expect FQ4 EPS of $1.78-$1.83, in-line with a $1.80 consensus.</li>\n<li>FQ3 gross margin fell 80 bps Y/Y to 38.4%. SG&amp;A spend rose 4% to $776.3M, slightly outpacing revenue growth of 3%.</li>\n<li>A $1.1B accelerated buyback was finished in December. $200M had been spent via BBBY's $2B buyback program as of Nov. 29.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2213525-bed-bath-and-beyond-eps-in-line-misses-on-revenue\" target=\"_blank\">FQ3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213645\" data-linked=\"Bed Bath &amp; Beyond -6.2% AH on revenue miss, slowing comps\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond -6.2% AH on revenue miss, slowing comps https://seekingalpha.com/news/2213645-bed-bath-and-beyond-minus-6_2-percent-ah-on-revenue-miss-slowing-comps?source=tweet\" data-url=\"https://seekingalpha.com/news/2213645-bed-bath-and-beyond-minus-6_2-percent-ah-on-revenue-miss-slowing-comps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213635\" data-ts=\"1420753133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMLP\" target=\"_blank\">GMLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213635-golar-lng-partners-in-7_17m-unit-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golar LNG Partners in 7.17M-unit secondary offering</a></h4><ul>\n<li>Golar LNG Partners (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GMLP\" title=\"Golar LNG Partners LP\">GMLP</a>) <font color=\"red\">-4.2%</font> AH on news it plans to sell 7.17M common units to Golar LNG (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GLNG\" title=\"Golar LNG Limited\">GLNG</a>), using the proceeds to fund part of the  recently announced contract with Keppel Shipyard to convert one of its  first generation liquefied natural gas carriers into a floating natural gas  liquefaction facility.</li>\n<li>The proceeds will be in addition to those expected to be  received over the next two years from the announced <a href=\"https://seekingalpha.com/news/2179335-golar-lng-partners-to-acquire-golar-eskimo-from-golar-lng-for-390m\" target=\"_blank\">$390M  sale</a> of the Golar Eskimo to GMLP.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213635\" data-linked=\"Golar LNG Partners in 7.17M-unit secondary offering\" data-tweet=\"$GMLP $GMLP $GLNG - Golar LNG Partners in 7.17M-unit secondary offering https://seekingalpha.com/news/2213635-golar-lng-partners-in-7_17m-unit-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/2213635-golar-lng-partners-in-7_17m-unit-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213505\" data-ts=\"1420751887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213505-chip-stocks-party-like-its-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chip stocks party like it&#39;s 2014</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/news/2207965-chip-stocks-hit-hard-amid-tech-selloff\" target=\"_blank\">Hit hard</a> on Tuesday amid a market rout, chip stocks have more than made up for it today: The Philadelphia Semi Index (<a href=\"https://seekingalpha.com/symbol/SOXX\" title=\"iShares PHLX SOX Semiconductor Sector Index ETF\">SOXX</a> <font color=\"green\">+3%</font>) handily exceeded the Nasdaq's 1.8% gain. The index posted a 1% gain yesterday.</li>     <li>Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+4.9%</font>) has been one of the standouts, more than recouping <a href=\"https://seekingalpha.com/news/2211135-analysts-stay-bullish-on-micron-in-spite-of-light-guidance\" target=\"_blank\">yesterday's </a>post-earnings losses. Ditto Freescale (<a href=\"https://seekingalpha.com/symbol/FSL\" title=\"Freescale Semiconductor Inc.\">FSL</a> <font color=\"green\">+9.2%</font>), which benefited from a Deutsche target hike, and <a href=\"https://seekingalpha.com/news/2213175-marvell-up-6_4-percent-after-mkm-makes-case-for-intel-deal\" target=\"_blank\">Marvell</a>, which got a lift from an MKM note. Others: <a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"green\">+3.8%</font>. <a href=\"https://seekingalpha.com/symbol/NXPI\" title=\"NXP Semiconductors\">NXPI</a> <font color=\"green\">+4.7%</font>. <a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/CY\" title=\"Cypress Semiconductor Corporation\">CY</a> <font color=\"green\">+6.1%</font>. CODE <font color=\"green\">+5.9%</font>. CAVM <font color=\"green\">+5.2%</font>. <a href=\"https://seekingalpha.com/symbol/SWKS\" title=\"Skyworks Solutions, Inc.\">SWKS</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/SLAB\" title=\"Silicon Laboratories, Inc.\">SLAB</a> <font color=\"green\">+4.5%</font>. <a href=\"https://seekingalpha.com/symbol/KLIC\" title=\"Kulicke and Soffa Industries, Inc.\">KLIC</a> <font color=\"green\">+3.8%</font>. <a href=\"https://seekingalpha.com/symbol/SMTC\" title=\"Semtech Corporation\">SMTC</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/ATML\" title=\"Atmel Corporation\">ATML</a> <font color=\"green\">+3.7%</font>. FCS <font color=\"green\">+4.2%</font>. <a href=\"https://seekingalpha.com/symbol/TSEM\" title=\"Tower Semiconductor Ltd.\">TSEM</a> <font color=\"green\">+4.2%</font>.</li>     <li>As is their custom, both <a href=\"https://seekingalpha.com/news/2206305-ces-chip-news-qualcomm-nvidia-broadcom-atmel\" target=\"_blank\">chipmakers</a> and <a href=\"https://seekingalpha.com/news/2206175-ces-product-news-hp-seagate-sandisk-garmin-lenovo\" target=\"_blank\">their clients</a> have been unveiling plenty of new products at CES.</li>     <li>ETFs: <a href=\"https://seekingalpha.com/symbol/SMH\" title=\"VanEck Vectors Semiconductor ETF\">SMH</a>, <a href=\"https://seekingalpha.com/symbol/XSD\" title=\"SPDR S&amp;P Semiconductor ETF\">XSD</a>, <a href=\"https://seekingalpha.com/symbol/PSI\" title=\"Invesco Dynamic Semiconductors Portfolio ETF\">PSI</a>, <a href=\"https://seekingalpha.com/symbol/SOXL\" title=\"Direxion Daily Semiconductor 3x Bull Shares ETF\">SOXL</a>, <a href=\"https://seekingalpha.com/symbol/USD\" title=\"ProShares Ultra Semiconductors ETF\">USD</a>, <a href=\"https://seekingalpha.com/symbol/SOXS\" title=\"Direxion Daily Semiconductor 3x Bear Shares ETF\">SOXS</a>, <a href=\"https://seekingalpha.com/symbol/SSG\" title=\"ProShares UltraShort Semiconductors ETF\">SSG</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213505\" data-linked=\"Chip stocks party like it&#39;s 2014\" data-tweet=\"$MU $SOXX $MU - Chip stocks party like it&#39;s 2014 https://seekingalpha.com/news/2213505-chip-stocks-party-like-its-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/2213505-chip-stocks-party-like-its-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213485\" data-ts=\"1420751705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213485-macys-to-restructure-holiday-comp-plus-2_7-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s to restructure; holiday comp +2.7%</a></h4><ul>\n<li>Macy's (NYSE:<a href=\"https://seekingalpha.com/symbol/M\" title=\"Macy's Inc.\">M</a>) reports holiday sales rose 2.7%.</li>\n<li>The mark is above the mid-point of Q4 comp guidance for 2% to 3%.</li>\n<li>The company maintains FY14 EPS guidance.</li>\n<li>In a separate announcement, Macy's indicates a restructuring and concentrated store closings will lead a greater focus on digital channels.</li>\n<li>All Macy's and Bloomingdale's will increase their ability to fulfill online orders.</li>\n<li>M <font color=\"red\">-1.9%</font> after-hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213485\" data-linked=\"Macy&#39;s to restructure; holiday comp +2.7%\" data-tweet=\"$M - Macy&#39;s to restructure; holiday comp +2.7% https://seekingalpha.com/news/2213485-macys-to-restructure-holiday-comp-plus-2_7-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/2213485-macys-to-restructure-holiday-comp-plus-2_7-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213415\" data-ts=\"1420751149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HELE\" target=\"_blank\">HELE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213415-helen-of-troy-beats-by-0_86-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helen of Troy beats by $0.86, beats on revenue</a></h4><ul>\n<li>Helen of Troy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HELE\" title=\"Helen of Troy Limited\">HELE</a>): Q3 EPS of $2.17 <font color=\"green\">beats by $0.86</font>.</li>\n<li>Revenue of $435.67M (+14.4% Y/Y) <font color=\"green\">beats by $22.23M</font>.</li>\n<li>Shares <font color=\"green\">+3.94%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213415\" data-linked=\"Helen of Troy beats by $0.86, beats on revenue\" data-tweet=\"$HELE - Helen of Troy beats by $0.86, beats on revenue https://seekingalpha.com/news/2213415-helen-of-troy-beats-by-0_86-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/2213415-helen-of-troy-beats-by-0_86-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213315\" data-ts=\"1420750576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213315-fda-clears-impax-combo-parkinsons-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Impax combo Parkinson&#39;s drug</a></h4><ul>\n<li>The FDA approves Impax Pharmaceuticals' (IPXL <font color=\"green\">+11.7%</font>) Rytary (cardidopa/levodopa extended release) for the treatment of Parkinson's disease, post-encephalitic parkinsonism and parkinsonism that may follow carbon monoxide intoxication and/or manganese intoxication.</li>\n<li>The company resubmitted its NDA in April after receiving a CRL in January pertaining to manufacturing issues.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/1670633-impax-files-parkinsons-drug\" target=\"_blank\">Impax files Parkinson's drug</a> (April 11, 2014)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213315\" data-linked=\"FDA clears Impax combo Parkinson&#39;s drug\" data-tweet=\"$AMRX - FDA clears Impax combo Parkinson&#39;s drug https://seekingalpha.com/news/2213315-fda-clears-impax-combo-parkinsons-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/2213315-fda-clears-impax-combo-parkinsons-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213305\" data-ts=\"1420750081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213305-boeing-silk-way-west-near-deal-for-three-747minus-8-freighters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing, Silk Way West near deal for three 747-8 freighters</a></h4><ul>     <li>Boeing (<a href=\"https://seekingalpha.com/symbol/BA\" title=\"The Boeing Company\">BA</a> <font color=\"green\">+1.7%</font>) is nearing an agreement to <a href=\"http://www.bloomberg.com/news/2015-01-08/boeing-sees-jumbo-jet-sales-drought-ending-on-silk-way-agreement.html\" target=\"_blank\">sell three 747-8 freighter airplanes</a> to Azerbaijan\u2019s  Silk Way West Airlines, a deal that would be a boost for Boeing\u2019s biggest, most-expensive model after 2014 ended with no net orders.</li>\n<li>Boeing says the companies are working toward a purchase agreement that would be  valued at $1.1B at list prices, without giving a projected timetable; Azerbaijan news media outlets are reporting that the deal was final.</li>\n<li>Jumbo jet sales have slowed as the air-cargo market proved slow to rebound  from the 2008 recession and airlines shifted long-distance travel  to more-efficient twin-engine models such as Boeing\u2019s 777 jetliner.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213305\" data-linked=\"Boeing, Silk Way West near deal for three 747-8 freighters\" data-tweet=\"$BA - Boeing, Silk Way West near deal for three 747-8 freighters https://seekingalpha.com/news/2213305-boeing-silk-way-west-near-deal-for-three-747minus-8-freighters?source=tweet\" data-url=\"https://seekingalpha.com/news/2213305-boeing-silk-way-west-near-deal-for-three-747minus-8-freighters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213285\" data-ts=\"1420749571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNA\" target=\"_blank\">NNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213285-navios-maritime-takes-delivery-and-employment-of-vlcc-mr2-tanker\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navios Maritime takes delivery and employment of VLCC, MR2 tanker</a></h4><ul>     <li>Navios Maritime Acquisition (<a href=\"https://seekingalpha.com/symbol/NNA\" title=\"Navios Maritime Acquisition Corporation\">NNA</a> <font color=\"green\">+6.8%</font>) says it has taken delivery of a VLCC and a MR2 product tanker, which are expected to generate a combined $12.1M in EBITDA this year.</li>     <li>NNA today took delivery of the Nave Sextans, a nearly 50K deadweight tonnage MR2 product tanker, which has been chartered to an unidentified customer for two years at $15.6K/day; late last month, it took ownership of the Nave Synergy, a crude carrier with nearly 300K deadweight tonnage that has been chartered for one year at almost $34K/day.</li>     <li>The two ships increases the NNA fleet to 38 vessels, including eight VLCCs, 26 product tankers and four chemical tankers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213285\" data-linked=\"Navios Maritime takes delivery and employment of VLCC, MR2 tanker\" data-tweet=\"$NNA - Navios Maritime takes delivery and employment of VLCC, MR2 tanker https://seekingalpha.com/news/2213285-navios-maritime-takes-delivery-and-employment-of-vlcc-mr2-tanker?source=tweet\" data-url=\"https://seekingalpha.com/news/2213285-navios-maritime-takes-delivery-and-employment-of-vlcc-mr2-tanker\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213235\" data-ts=\"1420747843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPR\" target=\"_blank\">IPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213235-parkervision-up-strongly-after-ipr-petition-denied\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ParkerVision up strongly after IPR petition denied</a></h4><ul>\n<li>The USPTO's Patent Trial and Appeal Board (PTAB) has fully denied a request by RPX and Michael Farmwald for an inter partes review (<a href=\"https://seekingalpha.com/symbol/IPR\" title=\"Intl Power plc ADS\">IPR</a>) of claims in ParkerVision (<a href=\"https://seekingalpha.com/symbol/PRKR\" title=\"ParkerVision, Inc.\">OTC:PRKR</a> <font color=\"green\">+7.3%</font>) patent #7,496,342 (<a href=\"http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=7,496,342.PN.&amp;OS=PN/7,496,342&amp;RS=PN/7,496,342\" target=\"_blank\">USPTO filing</a>). The patent is one of four pending appeal in ParkerVision's infringement suit against Qualcomm.</li>\n<li>The company notes one of the claims within the patent (claim 18) was among the 11 claims that a jury ruled Qualcomm was infringing.</li>\n<li>ParkerVision fell hard last month after RPX/Farmwald were <a href=\"https://seekingalpha.com/news/2188095-parkervision-to-face-ipr-trials-for-14-patent-claims\" target=\"_blank\">granted petitions </a>for an IPR of 14 claims in 3 patents, and denied for one claim.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213235\" data-linked=\"ParkerVision up strongly after IPR petition denied\" data-tweet=\"$IPR $IPR $PRKR - ParkerVision up strongly after IPR petition denied https://seekingalpha.com/news/2213235-parkervision-up-strongly-after-ipr-petition-denied?source=tweet\" data-url=\"https://seekingalpha.com/news/2213235-parkervision-up-strongly-after-ipr-petition-denied\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213175\" data-ts=\"1420745900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213175-marvell-up-6_4-percent-after-mkm-makes-case-for-intel-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell up 6.4% after MKM makes case for Intel deal</a></h4><ul>\n<li>In the wake of a Chinese media <a href=\"https://seekingalpha.com/news/2207905-marvell-spikes-on-report-of-potential-mobile-chip-unit-sale\" target=\"_blank\">report</a> stating a local firm is weighing a bid for Marvell's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRVL\" title=\"Marvell Technology Group, Ltd.\">MRVL</a>) mobile chip unit, <a href=\"http://online.barrons.com/articles/marvell-intel-wireless-deal-would-make-sense-1420733947\" target=\"_blank\">MKM argues</a> a sale of the business to Intel would be \"a solid win-win for both parties.\"</li>\n<li>MKM asserts buying Marvell would allow Intel to \"scale-up in its wireless and foundry businesses,\" and bolster its chances of succeeding in a very competitive mobile baseband market where Qualcomm/MediaTek still dominate.</li>\n<li>Meanwhile, Marvell could still see earnings grow 10% in spite of the loss of wireless sales (30% of total revenue), thanks to a 40% drop in R&amp;D and sales/marketing spend, and relatively low mobile gross margins (~45%). MKM also believes the deal could dull <a href=\"https://seekingalpha.com/news/1294592-marvell-slips-after-1_17b-patent-verdict-upheld\" target=\"_blank\">patent lawsuit</a> fears and allow Marvell to negotiate a favorable foundry deal with Intel.</li>\n<li>One potential roadblock: <a href=\"https://seekingalpha.com/news/2003445-positive-reactions-to-intels-spreadtrum-rda-deal\" target=\"_blank\">Intel's deals</a> with Chinese baseband vendors/Marvell rivals Spreadtrum and RDA present a conflict of interest.</li>\n<li>Shares <font color=\"green\">+15%</font> since the Chinese report surfaced on Tuesday. Today's gains are aided by a 3.1% rise for the Philadelphia Semi Index.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213175\" data-linked=\"Marvell up 6.4% after MKM makes case for Intel deal\" data-tweet=\"$MRVL - Marvell up 6.4% after MKM makes case for Intel deal https://seekingalpha.com/news/2213175-marvell-up-6_4-percent-after-mkm-makes-case-for-intel-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/2213175-marvell-up-6_4-percent-after-mkm-makes-case-for-intel-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213165\" data-ts=\"1420745633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNX\" target=\"_blank\">CNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213165-watch-for-entry-points-in-better-quality-coal-names-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Watch for entry points in better quality coal names, analyst says</a></h4><ul>     <li>It\u2019s time for investors to start <a href=\"http://blogs.barrons.com/stockstowatchtoday/2015/01/08/coal-miners-the-enemy-of-your-enemy-is-your-friend/\" target=\"_blank\">looking for entry points</a> in quality coal miners such as Consol Energy (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+1.5%</font>), Cloud Peak Energy (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+4.1%</font>) and Peabody Energy (<a href=\"https://seekingalpha.com/symbol/BTU\" title=\"Peabody Energy Corp.\">BTU</a> <font color=\"red\">-0.2%</font>), J.P. Morgan says in the hope that funding problems now confronting the U.S. shale revolution will lead to a more balanced U.S. gas market and better prospects for coal.</li>     <li>While the seaborne market is lackluster, JPM believes it sees a positive story emerging for the U.S. coal industry due to the changing landscape in U.S.  E&amp;P driven by falling oil prices, which should lead to a tighter natural gas market in late 2015 and beyond and spark positive movement in depressed coal names.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213165\" data-linked=\"Watch for entry points in better quality coal names, analyst says\" data-tweet=\"$CNX $CNX $CLDPQ - Watch for entry points in better quality coal names, analyst says https://seekingalpha.com/news/2213165-watch-for-entry-points-in-better-quality-coal-names-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/2213165-watch-for-entry-points-in-better-quality-coal-names-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213145\" data-ts=\"1420744982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EC\" target=\"_blank\">EC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213145-ecopetrol-said-to-seek-sale-of-stake-in-colombia-s-invercolsa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ecopetrol said to seek sale of stake in Colombia\u2019s Invercolsa</a></h4><ul>     <li>Ecopetrol (<a href='https://seekingalpha.com/symbol/EC' title='Ecopetrol S.A.'>EC</a> <font color='green'>+3.1%</font>) is <a href=\"http://www.businessweek.com/news/2015-01-08/ecopetrol-said-to-seek-sale-of-stake-in-colombia-s-invercolsa\" target=\"_blank\">exploring a sale</a> of its stake in gas investment company Invercolsa, Bloomberg reports, following a multiyear legal battle over part of the holding.</li>     <li>EC's 43% stake in Invercolsa, which invests in natural gas transportation and distribution in Colombia, had a book value of ~$112M at year-end 2013.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2213145\" data-linked=\"Ecopetrol said to seek sale of stake in Colombia\u2019s Invercolsa\" data-tweet=\"$EC - Ecopetrol said to seek sale of stake in Colombia\u2019s Invercolsa https://seekingalpha.com/news/2213145-ecopetrol-said-to-seek-sale-of-stake-in-colombia-s-invercolsa?source=tweet\" data-url=\"https://seekingalpha.com/news/2213145-ecopetrol-said-to-seek-sale-of-stake-in-colombia-s-invercolsa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213125\" data-ts=\"1420744553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEN\" target=\"_blank\">ATEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213125-a10-networks-soars-following-d-a-davidson-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A10 Networks soars following D.A. Davidson upgrade</a></h4><ul>\n<li>With shares trading at a fraction of last March's $15 IPO price following a <a href=\"https://seekingalpha.com/news/2020895-a10-networks-minus-34_1-percent-on-q3-warning\" target=\"_blank\">bumpy</a> 2014, D.A. Davidson has upgraded A10 Networks (<a href=\"https://seekingalpha.com/symbol/ATEN\" title=\"A10 Networks, Inc.\">ATEN</a> <font color=\"green\">+10.9%</font>) to Buy.</li>\n<li>The application delivery controller vendor goes for only ~1x 2015E sales after backing out $107M in cash. Q4 results arrive on Feb. 11.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213125\" data-linked=\"A10 Networks soars following D.A. Davidson upgrade\" data-tweet=\"$ATEN - A10 Networks soars following D.A. Davidson upgrade https://seekingalpha.com/news/2213125-a10-networks-soars-following-d-a-davidson-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2213125-a10-networks-soars-following-d-a-davidson-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213085\" data-ts=\"1420743103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213085-credit-suisse-upgrades-alcatel-expects-strong-cash-flow-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse upgrades Alcatel, expects strong cash flow growth</a></h4><ul>\n<li>Believing the company \"remains on track to turn into a specialist in IP networks,\" Credit Suisse <a href=\"http://votreargent.lexpress.fr/bourse/alcatel-lucent-credit-suisse-releve-son-opinion_1638614.html\" target=\"_blank\">has upgraded</a> Alcatel-Lucent (ALU <font color=\"green\">+2.7%</font>) to Outperform, and hiked its target by \u20ac0.50 to \u20ac3.75 ($4.69).</li>\n<li>CS sees Alcatel respectively delivering 2015 and 2016 EPS of \u20ac0.23 and \u20ac0.30. It also forecasts cash flow (exc. restructuring, pension, and interest expenses) will turn positive this year, and reach \u20ac550M next year.</li>\n<li>The firm adds shares sports a forward <a href=\"http://www.investopedia.com/terms/e/enterprisevaluesales.asp\" target=\"_blank\">EV/sales</a> ratio of just 0.55x, and suggests Alcatel could unload its underperforming mobile infrastructure unit (<a href=\"https://seekingalpha.com/news/2186625-alcatel-lucent-jumps-on-new-nokia-merger-report\" target=\"_blank\">perhaps to Nokia?</a>).</li>\n<li>Shares are posting healthy gains with the help of rallies in both U.S. and European markets.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213085\" data-linked=\"Credit Suisse upgrades Alcatel, expects strong cash flow growth\" data-tweet=\"$NOK - Credit Suisse upgrades Alcatel, expects strong cash flow growth https://seekingalpha.com/news/2213085-credit-suisse-upgrades-alcatel-expects-strong-cash-flow-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/2213085-credit-suisse-upgrades-alcatel-expects-strong-cash-flow-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213045\" data-ts=\"1420742545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELOS\" target=\"_blank\">ELOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213045-syneron-reports-preliminary-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syneron reports preliminary Q4 results</a></h4><ul><li>Thinly-traded Syneron Medical (<a href=\"https://seekingalpha.com/symbol/ELOS\" title=\"Syneron Medical Ltd.\">ELOS</a> <font color=\"green\">+21%</font>) jumps on a 4x surge in volume, albeit on turnover of only 267K, in response to its report of preliminary Q4 revenue of $72M - 74M, up 20 - 24% from a year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"2213045\" data-linked=\"Syneron reports preliminary Q4 results\" data-tweet=\"$ELOS - Syneron reports preliminary Q4 results https://seekingalpha.com/news/2213045-syneron-reports-preliminary-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/2213045-syneron-reports-preliminary-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213025\" data-ts=\"1420742222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213025-valeant-pharma-up-on-updated-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant Pharma up on updated guidance</a></h4><ul><li>Valeant Pharmaceuticals (VRX <font color='green'>+6.2%</font>) heads north on double normal volume after it <a href=\"http://www.sec.gov/Archives/edgar/data/885590/000119312515004538/d847143dex991.htm\" target=\"_blank\">updated </a>its Q4 and 2015 guidance.</li><li><b>Q4</b>: Revenues: ~$2.2B from $2.1B - 2.3B; EPS: at least $2.55 from $2.45 - 2.55; CF Ops: ~$600M (unch).</li><li><strong>2015</strong>: Revenues: $9.2B - 9.3B from ~$9.1B; EPS: $10.10 - 10.40 from ~$10.00; CF Ops: &gt;$3.1B from ~$3.1B.</li></ul><div class=\"tiny-share-widget\" data-id=\"2213025\" data-linked=\"Valeant Pharma up on updated guidance\" data-tweet=\"$BHC - Valeant Pharma up on updated guidance https://seekingalpha.com/news/2213025-valeant-pharma-up-on-updated-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2213025-valeant-pharma-up-on-updated-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213015\" data-ts=\"1420742103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROVI\" target=\"_blank\">ROVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213015-rovi-surges-on-guidance-buyback-plans-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rovi surges on guidance, buyback plans, upgrade</a></h4><ul>\n<li>Rovi (<a href=\"https://seekingalpha.com/symbol/ROVI\" title=\"Rovi Corporation\">ROVI</a> <font color=\"green\">+6.2%</font>) is up sharply after providing better-than-feared <a href=\"https://seekingalpha.com/news/2211025-rovi-narrows-2014-guidance-offers-2015-outlook\" target=\"_blank\">2015 guidance </a>ahead of its analyst day, and stating it plans to buy back 5M shares this year. The programming guide/content IP licensing firm is now about $2 away from a 52-week high of $25.34.</li>\n<li>Helping Rovi's cause: Pac Crest has upgraded to Outperform, and set a $31 target.</li>\n<li>\n<a href=\"http://ir.rovicorp.com/interactive/lookandfeel/4206196/2015%20Rovi%20Investor%20Day_Print.pdf\" target=\"_blank\">Analyst day slides</a> (.pdf)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213015\" data-linked=\"Rovi surges on guidance, buyback plans, upgrade\" data-tweet=\"$ROVI - Rovi surges on guidance, buyback plans, upgrade https://seekingalpha.com/news/2213015-rovi-surges-on-guidance-buyback-plans-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2213015-rovi-surges-on-guidance-buyback-plans-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2213005\" data-ts=\"1420741752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGEN\" target=\"_blank\">RGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2213005-repligen-up-on-preliminary-revenue-numbers-and-2015-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repligen up on preliminary revenue numbers and 2015 guidance</a></h4><ul>\n<li>Repligen (<a href=\"https://seekingalpha.com/symbol/RGEN\" title=\"Repligen Corporation\">RGEN</a> <font color=\"green\">+17.7%</font>) moves up on 50% higher volume in response to its announcement of preliminary revenue of $63M - 63.5M for 2014. Estimated product revenue is $60.0M - 60.5M, an increase from previous guidance of $58M - 60M and up 26 - 27% from 2013. It will report final results in March.</li>\n<li>Separately, the company received a $1M milestone payment from Pfizer under its license agreement for the development of compounds to potentially treat spinal muscular dystrophy.</li>\n<li>\n<strong>2015 Guidance</strong>: Revenues: $69M - 72M; Gross Margin: &gt;55%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2213005\" data-linked=\"Repligen up on preliminary revenue numbers and 2015 guidance\" data-tweet=\"$RGEN - Repligen up on preliminary revenue numbers and 2015 guidance https://seekingalpha.com/news/2213005-repligen-up-on-preliminary-revenue-numbers-and-2015-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2213005-repligen-up-on-preliminary-revenue-numbers-and-2015-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212995\" data-ts=\"1420740920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212995-solar-stocks-bounce-as-market-rallies-deutsche-pounds-table\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks bounce as market rallies, Deutsche pounds table</a></h4><ul>     <li>Deutsche's Vishal Shah, <a href=\"https://seekingalpha.com/news/2157455-deutsche-solar-to-see-almost-no-impact-from-oil-prices\" target=\"_blank\">bullish</a> on solar for a long time, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130847/deutsche-banks-2015-solar-outlook-top-picks?source=sa\" target=\"_blank\">asserts</a> the \"recent volatility in solar stocks, driven largely by oil price weakness, presents an attractive entry point for investors as we expect 2015 to be a year of stable industry pricing and accelerating volume growth.\"</li>     <li>Shah expects solar to see a \"balanced supply/demand outlook as strong demand from the US and improving demand from China/other emerging solar markets offsets any potential demand weakness in the UK/Japan.\"</li>     <li>He observes oil accounts for just ~5% of global electricity output, and sees both solar project pipelines/margins and module margins rising in 2015. <a href=\"https://seekingalpha.com/news/2182595-u-s-to-impose-tariffs-on-solar-equipment-from-china-taiwan\" target=\"_blank\">Tariffs</a> against Chinese module vendors are expected to be \"completely removed.\"</li>     <li>His top picks are SolarCity (SCTY <font color=\"green\">+3.3%</font>), SunEdison (SUNE <font color=\"green\">+4.1%</font>), SunPower (<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"green\">+6.1%</font>), and Vivint (<a href=\"https://seekingalpha.com/symbol/VSLR\" title=\"Vivint Solar\">VSLR</a> <font color=\"green\">+0.3%</font>); the first three are faring quite well today. Yingli (<a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+0.2%</font>), however, has been downgraded to Hold due to balance sheet and financial flexibility concerns.</li>     <li>Other major gainers: <a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a> <font color=\"green\">+5.4%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+3.7%</font>. <a href=\"https://seekingalpha.com/symbol/RGSE\" title=\"RGS Energy, Inc.\">RGSE</a> <font color=\"green\">+5.2%</font>. <a href=\"https://seekingalpha.com/symbol/TERP\" title=\"TerraForm Power, Inc.\">TERP</a> <font color=\"green\">+3.2%</font>.</li>     <li>SunEdison announced today it has bought new wind turbines that will allow it to build up to 1.6GW of wind projects that qualify for U.S. tax credits. The purchase follows the company's <a href=\"https://seekingalpha.com/news/2132845-sunedison-terraform-buying-first-wind-for-up-to-2_4b\" target=\"_blank\">$2.4B deal</a> to buy project developer First Wind.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a>, <a href=\"https://seekingalpha.com/symbol/KWT\" title=\"VanEck Vectors Solar Energy ETF\">KWT</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212995\" data-linked=\"Solar stocks bounce as market rallies, Deutsche pounds table\" data-tweet=\"$TSLA $TSLA $SUNEQ - Solar stocks bounce as market rallies, Deutsche pounds table https://seekingalpha.com/news/2212995-solar-stocks-bounce-as-market-rallies-deutsche-pounds-table?source=tweet\" data-url=\"https://seekingalpha.com/news/2212995-solar-stocks-bounce-as-market-rallies-deutsche-pounds-table\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212945\" data-ts=\"1420739360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212945-greenbrier-upgraded-to-buy-at-stifel-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier upgraded to Buy at Stifel after strong quarter</a></h4><ul>     <li>Greenbrier (<a href=\"https://seekingalpha.com/symbol/GBX\" title=\"The Greenbrier Companies, Inc.\">GBX</a> <font color=\"green\">+2.8%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130406/update-stifel-upgrades-the-greenbrier-companies-on-1q15-\" target=\"_blank\">upgraded to Buy</a> from Hold with a $66 price target at Stifel following strong <a href=\"https://seekingalpha.com/news/2209045-more-on-greenbiers-fq1\" target=\"_blank\">FQ1 earnings</a> and guidance, citing added confidence about GBX's margin  enhancement and return-on-capital improvement initiatives in the manufacturing and repair/wheels segments.</li>     <li>DA Davidson maintains its Buy rating, saying recent concerns over potential cancellations related to oil price declines are overblown and noting that inevitable new tank car safety regulations are not contingent upon energy prices (Briefing.com).</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212945\" data-linked=\"Greenbrier upgraded to Buy at Stifel after strong quarter\" data-tweet=\"$GBX - Greenbrier upgraded to Buy at Stifel after strong quarter https://seekingalpha.com/news/2212945-greenbrier-upgraded-to-buy-at-stifel-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/2212945-greenbrier-upgraded-to-buy-at-stifel-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212925\" data-ts=\"1420739222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212925-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/BIND\" title=\"BIND Therapeutics, Inc.\">BIND</a> <font color=\"green\">+62%</font>. <a href=\"https://seekingalpha.com/symbol/EPRS\" title=\"EPIRUS Biopharmaceuticals, Inc\">EPRS</a> <font color=\"green\">+42%</font>. <a href=\"https://seekingalpha.com/symbol/PDFS\" title=\"PDF Solutions, Inc.\">PDFS</a> <font color=\"green\">+28%</font>. <a href=\"https://seekingalpha.com/symbol/ELOS\" title=\"Syneron Medical Ltd.\">ELOS</a> <font color=\"green\">+22%</font>. BIOD <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/NBIX\" title=\"Neurocrine Biosciences, Inc.\">NBIX</a> <font color=\"green\">+20%</font>. VLCCF <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/PSTR\" title=\"PostRock Energy Corporation\">OTC:PSTR</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/PHMD\" title=\"PhotoMedex, Inc.\">PHMD</a> <font color=\"green\">+18%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/NEFF\" title=\"Neff Corp.\">NEFF</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CASM\" title=\"CAS Medical Systems, Inc.\">CASM</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/JOB\" title=\"GEE Group, Inc.\">JOB</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/BWEN\" title=\"Broadwind Energy, Inc.\">BWEN</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/STML\" title=\"Stemline Therapeutics\">STML</a> <font color=\"red\">-10%</font>. AOI <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/PODD\" title=\"Insulet Corporation\">PODD</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/MBII\" title=\"Marrone Bio Innovations, Inc.\">MBII</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212925\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$BIND $EPRS $PDFS - Midday Gainers / Losers https://seekingalpha.com/news/2212925-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2212925-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212915\" data-ts=\"1420739087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRDS\" target=\"_blank\">CRDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212915-crossroads-expands-oem-deal-with-fuji\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crossroads expands OEM deal with Fuji</a></h4><ul>\n<li>Crossroads (<a href=\"https://seekingalpha.com/symbol/CRDS\" title=\"Crossroads Systems, Inc.\">CRDS</a> <font color=\"green\">+3.6%</font>) has expanded its storage OEM deal with Fuji's recording media unit to (already covers the U.S.) to include Canada and South America. Also, the expanded deal \"provides considerations for further broadening distribution into additional global markets.\"</li>\n<li>The OEM deal is tied to Fuji's <a href=\"http://www.dternity.net/overview\" target=\"_blank\">Dternity</a> NAS data archiving/tape storage systems.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212915\" data-linked=\"Crossroads expands OEM deal with Fuji\" data-tweet=\"$CRDS - Crossroads expands OEM deal with Fuji https://seekingalpha.com/news/2212915-crossroads-expands-oem-deal-with-fuji?source=tweet\" data-url=\"https://seekingalpha.com/news/2212915-crossroads-expands-oem-deal-with-fuji\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212865\" data-ts=\"1420738213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212865-invensense-down-3_9-percent-in-spite-of-market-rally-product-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense down 3.9% in spite of market rally, product launches</a></h4><ul>\n<li>Though the Philadelphia Semi Index is up 2.6% amid a broad market rally, InvenSense (NYSE:<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a>) has sold off. 1.33M shares have been traded thus far vs. a 3-month daily average of 2.59M.</li>\n<li>Like many other chipmakers, InvenSense has been busy this week at CES. The company has announced: 1) An SoC (the ICM-30630) that combines a 6-axis motion sensor with a sensor hub, flash memory, SRAM, and a software framework. 2) Six new microphones (a by-product of <a href=\"https://seekingalpha.com/news/1327302-invensense-buying-analog-devices-microphone-unit\" target=\"_blank\">the ADI deal</a>), including one declared to the world's smallest MEMS microphone and another said to the world's lowest-power <a href=\"http://en.wikipedia.org/wiki/Pulse-density_modulation\" target=\"_blank\">PDM</a> microphone (meant for always-on applications).</li>\n<li>The SoC contains an ARM microcontroller and two motion processors that offload all motion-processing tasks from a device's CPU. InvenSense asserts it \"disrupts the traditional discrete sensor subsystem in many applications by providing a true turn-key and open solution in the same footprint as competitive sensor only devices.\" The company bought a pair of motion-processing/positioning tech firms <a href=\"https://seekingalpha.com/news/1832465-invensense-buying-motion-processing-positioning-tech-firms\" target=\"_blank\">last summer</a>.</li>\n<li>\n<strong>Update: </strong>Possibly affecting InvenSense: Several law firms have announced <a href=\"http://finance.yahoo.com/news/robbins-geller-rudman-dowd-llp-011900440.html\" target=\"_blank\">class-action suits</a> over the last two days, alleging management mislead investors prior to the release of <a href=\"https://seekingalpha.com/news/2067925-invensense-minus-26_2-percent-ah-on-fq2-miss-guidance-gm-drop\" target=\"_blank\">soft guidance</a> on Oct. 28.</li>\n<li>\n<strong>Update 2: </strong>SA author <a href=\"https://seekingalpha.com/article/2807735-update-why-invensense-is-falling-while-other-chip-stocks-rise\" target=\"_blank\">Eskela</a> notes Intel's <a href=\"https://seekingalpha.com/news/2208865-intel-dives-deep-into-wearables\" target=\"_blank\">Curie</a> module (unveiled on Tuesday night at CES) could be worrying investors, and argues concerns are overblown. Curie, aimed at wearables and housed in a button-sized package, features a 6-axis accelerometer/gyroscope to go with a Quark CPU, flash memory, a sensor hub, and a Bluetooth radio.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212865\" data-linked=\"InvenSense down 3.9% in spite of market rally, product launches\" data-tweet=\"$INVN - InvenSense down 3.9% in spite of market rally, product launches https://seekingalpha.com/news/2212865-invensense-down-3_9-percent-in-spite-of-market-rally-product-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/2212865-invensense-down-3_9-percent-in-spite-of-market-rally-product-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212835\" data-ts=\"1420737842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSX\" target=\"_blank\">BSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212835-leerink-upgrades-boston-scientific\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink upgrades Boston Scientific</a></h4><ul><li>Leerink Partners <a href=\"http://www.thestreet.com/story/13004777/1/boston-scientific-bsx-stock-boosted-today-by-leerink-upgrade.html?puc=yahoo&amp;cm_ven=YAHOO\" target=\"_blank\">upgrades </a>Boston Scientific (<a href=\"https://seekingalpha.com/symbol/BSX\" title=\"Boston Scientific Corporation\">BSX</a> <font color=\"green\">+4%</font>) to Outperform from Market Perform and raises its price target to $18 from $15 citing results from the company's growth plans.</li></ul><div class=\"tiny-share-widget\" data-id=\"2212835\" data-linked=\"Leerink upgrades Boston Scientific\" data-tweet=\"$BSX - Leerink upgrades Boston Scientific https://seekingalpha.com/news/2212835-leerink-upgrades-boston-scientific?source=tweet\" data-url=\"https://seekingalpha.com/news/2212835-leerink-upgrades-boston-scientific\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212825\" data-ts=\"1420737248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212825-halozyme-up-on-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme up on upgrade</a></h4><ul>\n<li>Halozyme (<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"green\">+11.3%</font>) moves up on a 4x surge in volume after MLV &amp; Co. analyst Arlinda Lee <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130885/update-mlv-co-raises-pt-on-halozyme-therapeutics-on-prom?source=sa\" target=\"_blank\">reiterated </a>her Buy recommendation and raised the price target from $12 to $15 on the basis of positive interim results from a Phase 2 trial evaluating <a href=\"http://www.halozyme.com/Products-And-Pipeline/Pipeline/PEGPH20/default.aspx\" target=\"_blank\">PEGPH20 </a>in pancreatic cancer.</li>\n<li>PEGPH20 has Orphan Drug status in Europe and the U.S. in addition to Fast Track status in the U.S.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/1964895-halozyme-pancreatic-cancer-drug-candidate-fast-trackd\" target=\"_blank\">Halozyme pancreatic cancer drug candidate Fast Track'd</a> (Sept. 3, 2014)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2013425-halozyme-plus-4_2-percent-ah-cancer-drug-gets-orphan-designation\" target=\"_blank\">Halozyme +4.2% AH; cancer drug gets orphan designation</a> (Oct. 2, 2014)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212825\" data-linked=\"Halozyme up on upgrade\" data-tweet=\"$HALO - Halozyme up on upgrade https://seekingalpha.com/news/2212825-halozyme-up-on-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2212825-halozyme-up-on-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212785\" data-ts=\"1420736598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212785-bullish-breakout-for-exelixis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bullish breakout for Exelixis</a></h4><ul>\n<li>Exelixis (<a href=\"https://seekingalpha.com/symbol/EXEL\" title=\"Exelixis, Inc.\">EXEL</a> <font color=\"green\">+14.1%</font>) breaks out of brief consolidation on a 3x surge in volume. Shares have jumped over 50% since Christmas. Yesterday, the company extended its distribution deal with Swedish Orphan Biovitrum for five years.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2209825-exelixis-restructures-contract-with-swedish-orphan\" target=\"_blank\">Exelixis restructures contract with Swedish Orphan</a> (Jan. 7)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212785\" data-linked=\"Bullish breakout for Exelixis\" data-tweet=\"$EXEL - Bullish breakout for Exelixis https://seekingalpha.com/news/2212785-bullish-breakout-for-exelixis?source=tweet\" data-url=\"https://seekingalpha.com/news/2212785-bullish-breakout-for-exelixis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212755\" data-ts=\"1420735989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPRS\" target=\"_blank\">EPRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212755-sandoz-success-powers-epirus-bio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sandoz success powers Epirus Bio</a></h4><ul>\n<li>Investors show thinly-traded nano cap Epirus Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/EPRS\" title=\"EPIRUS Biopharmaceuticals, Inc\">EPRS</a> <font color=\"green\">+27.9%</font>) some love after yesterday's positive Ad Comm vote for Sandoz's biosimilar filgrastim. Shares are up on a 6x surge in volume albeit on turnover of only 150K.</li>\n<li>Epirus' lead product is <a href=\"http://www.epirusbiopharma.com/products/bow015-infliximab.php\" target=\"_blank\">BOW015 </a>(infliximab), a biosimilar to Janssen's (<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a> <font color=\"green\">+0.8%</font>) <a href=\"http://www.remicade.com/home?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=Brand+-+Exact&amp;utm_term=remicade&amp;utm_content=Branded+-+General%7Cmkwid%7CseZsUhYc6_dc%7Cpcrid%7C33705340568\" target=\"_blank\">Remicade</a>. The product is currently marketed in India by Ranbaxy Laboratories Limited. A global Phase 3 trial to support regulatory submissions in other markets will commence this year.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2211165-fda-ad-comm-gives-thumbs-up-to-sandoz-biosimilar-filgrastim\" target=\"_blank\">FDA Ad Comm gives thumbs up to Sandoz biosimilar filgrastim</a> (Jan. 7)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212755\" data-linked=\"Sandoz success powers Epirus Bio\" data-tweet=\"$EPRS $EPRS $JNJ - Sandoz success powers Epirus Bio https://seekingalpha.com/news/2212755-sandoz-success-powers-epirus-bio?source=tweet\" data-url=\"https://seekingalpha.com/news/2212755-sandoz-success-powers-epirus-bio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212725\" data-ts=\"1420735145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212725-yahoo-plus-2_2-percent-aol-plus-4_8-percent-after-starboard-steps-up-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yahoo +2.2%, AOL +4.8% after Starboard steps up pressure</a></h4><ul>\n<li>Though Marissa Mayer (YHOO) is <a href=\"https://seekingalpha.com/news/1842495-report-armstrong-wants-a-yahoo-aol-deal-but-mayer-not-a-fan\" target=\"_blank\">reportedly uninterested</a> in a deal and Tim Armstrong (NYSE:<a href=\"https://seekingalpha.com/symbol/AOL\" title=\"AOL Inc.\">AOL</a>) <a href=\"https://seekingalpha.com/news/2211275-aol-chief-dismisses-merger-talk\" target=\"_blank\">has dismissed</a> the M&amp;A speculation swirling around his company, activist Starboard Value is once more reiterating its call for a Yahoo/AOL merger.</li>\n<li>Starboard argues a merger would yield cost synergies of $1B-$1.5B/year, help Yahoo carry out \"a tax-efficient separation\" of its Alibaba/Yahoo Japan stakes, and create \"a strong growth platform given AOL's progress in mobile and video advertising.\"</li>\n<li>The firm also says it's \"increasingly concerned\" about <a href=\"https://seekingalpha.com/news/2202675-report-yahoo-considered-acquiring-scripps-networks-updated\" target=\"_blank\">reports</a> stating Yahoo is thinking of making a big media acquisition with its Alibaba IPO proceeds. In addition, it's not happy with speculation Yahoo is \"considering a cash-rich split-off as a structure to separate its non-core minority equity interests,\" rather than \"a spin-off structure or other available alternatives to unlock the full value of the stakes in Alibaba and Yahoo Japan.\"</li>\n<li>Yahoo has said it will offer more details about its plans to tax-efficiently monetize its remaining Alibaba stake during its Q4 earnings CC (set for Jan. 27).</li>\n<li>Both Yahoo and AOL are rallying. The Nasdaq is up 1.7%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212725\" data-linked=\"Yahoo +2.2%, AOL +4.8% after Starboard steps up pressure\" data-tweet=\"$AABA $AABA $AOL - Yahoo +2.2%, AOL +4.8% after Starboard steps up pressure https://seekingalpha.com/news/2212725-yahoo-plus-2_2-percent-aol-plus-4_8-percent-after-starboard-steps-up-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/2212725-yahoo-plus-2_2-percent-aol-plus-4_8-percent-after-starboard-steps-up-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212695\" data-ts=\"1420734381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEN\" target=\"_blank\">WEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212695-restaurant-stock-picks-from-citi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restaurant stock picks from Citi</a></h4><ul> <li>Citi takes a bullish view on select names in the restaurant sector.</li> <li>Wendy's (<a href=\"https://seekingalpha.com/symbol/WEN\" title=\"The Wendy's Company\">WEN</a> <font color=\"green\">+1%</font>) is <a href=\"http://www.analystratings.net/stocks/NYSE/WEN/\" target=\"_blank\">initiated</a> at Buy with a $11 price target. Analyst Gregory Badishkanian sees some of the company's initiatives helping to draw in millennials.</li> <li>Coverage on Chipotle (<a href=\"https://seekingalpha.com/symbol/CMG\" title=\"Chipotle Mexican Grill, Inc.\">CMG</a> <font color=\"green\">+3.5%</font>) is assumed again at a Buy with a $809 PT. Shares of CMG are at an all-time high after taking out $700 earlier this week.</li> <li>The investment firm is also backing Restaurant Brands (<a href=\"https://seekingalpha.com/symbol/QSR\" title=\"Restaurant Brands International Inc.\">QSR</a> <font color=\"green\">+2.7%</font>) and Brinker International (<a href=\"https://seekingalpha.com/symbol/EAT\" title=\"Brinker International, Inc.\">EAT</a> <font color=\"green\">+1.1%</font>) for gains with resumed Buy ratings.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212695\" data-linked=\"Restaurant stock picks from Citi\" data-tweet=\"$WEN $WEN $CMG - Restaurant stock picks from Citi https://seekingalpha.com/news/2212695-restaurant-stock-picks-from-citi?source=tweet\" data-url=\"https://seekingalpha.com/news/2212695-restaurant-stock-picks-from-citi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212655\" data-ts=\"1420733992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIXI\" target=\"_blank\">ZIXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212655-zix-soars-following-buyback-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zix soars following buyback announcement</a></h4><ul><li>After having sold off in late December/early January, Zix (<a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a> <font color='green'>+8%</font>) has surged in response to its <a href=\"https://seekingalpha.com/news/2210905-zix-launches-new-10m-buyback\" target=\"_blank\">$10M buyback announcement</a>.</li><li>Volume (85K shares vs. a 3-month daily average of 264K) has been moderate thus far.</li></ul><div class=\"tiny-share-widget\" data-id=\"2212655\" data-linked=\"Zix soars following buyback announcement\" data-tweet=\"$ZIXI - Zix soars following buyback announcement https://seekingalpha.com/news/2212655-zix-soars-following-buyback-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/2212655-zix-soars-following-buyback-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212615\" data-ts=\"1420733364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEEV\" target=\"_blank\">VEEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212615-veeva-zulily-pop-on-stifel-upgrade-coverage-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veeva, Zulily pop on Stifel upgrade, coverage launch</a></h4><ul>\n<li>While <a href=\"https://seekingalpha.com/news/2212325-google-priceline-lower-on-stifel-downgrades\" target=\"_blank\">downgrading</a> Google, Priceline, and TripAdvisor, Stifel has upgraded Veeva (<a href=\"https://seekingalpha.com/symbol/VEEV\" title=\"Veeva Systems Inc.\">VEEV</a> <font color=\"green\">+3.3%</font>) to Buy, and launched coverage on Zulily (<a href=\"https://seekingalpha.com/symbol/ZU\" title=\"Zulily, Inc.\">ZU</a> <font color=\"green\">+5.6%</font>) with a Buy and $30 target.</li>\n<li>Analyst Tom Roderick, who maintains a $36 target for Veeva, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130336/stifel-upgrades-veeva-systems-as-shares-are-cheaper-attr\" target=\"_blank\">declares</a> the company's <a href=\"http://www.veeva.com/vault/\" target=\"_blank\">Vault</a> cloud life sciences content management software to be a \"vertical category killer\" that has dramatically exceeded initial expectations. He also notes shares have fallen 33% since Stifel launched coverage on Veeva at Hold.</li>\n<li>Meanwhile, colleague Scott Devitt <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130545/update-stifel-initiates-coverage-on-zulily-on-buying-opp\" target=\"_blank\">argues</a> beaten-down Zulily's \"flash sales model, exclusive content, and growing target audience create a differentiated platform with a solid growth profile and limited inventory risk,\" and likes its competitive positioning relative to both other specialty e-commerce names and major offline discount retailers.</li>\n<li>Zulily currently sports an estimated 2016 EV/sales multiple of just 1x, roughly in-line with e-commerce peers but below discount retailers such as TJ Maxx and Ross. Devitt considers a 1.4x multiple more fitting.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212615\" data-linked=\"Veeva, Zulily pop on Stifel upgrade, coverage launch\" data-tweet=\"$VEEV $VEEV $ZU - Veeva, Zulily pop on Stifel upgrade, coverage launch https://seekingalpha.com/news/2212615-veeva-zulily-pop-on-stifel-upgrade-coverage-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/2212615-veeva-zulily-pop-on-stifel-upgrade-coverage-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212565\" data-ts=\"1420732655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212565-tractor-supply-climbs-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tractor Supply climbs after upgrade</a></h4><ul><li>Tractor Supply (<a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a> <font color='green'>+4.5%</font>) is on the rise following an <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+Tractor+Supply+Company+%28TSCO%29+to+Buy/10148424.html\" target=\"_blank\">upgrade</a> to Buy from Deutsche Bank.</li><li>\"After moving to a Hold in January 2014 on deflationary headwinds and more difficult cost compares...we believe the environment is friendlier in 2015,\" said analyst Adam Sindler.</li></ul><div class=\"tiny-share-widget\" data-id=\"2212565\" data-linked=\"Tractor Supply climbs after upgrade\" data-tweet=\"$TSCO - Tractor Supply climbs after upgrade https://seekingalpha.com/news/2212565-tractor-supply-climbs-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2212565-tractor-supply-climbs-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212525\" data-ts=\"1420732142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RASF\" target=\"_blank\">RASF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212525-rait-financial-taberna-exit-not-material-to-dividends-or-book\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RAIT Financial: Taberna exit not material to dividends or book</a></h4><ul>\n<li>Though RAIT Financial (RAS <font color=\"green\">+4.4%</font>) will take a non-cash charge of $227.1M in 2014 and a one-time reduction of GAAP equity of $214M, the deconsolidation of the Taberna securitizations will not materially impact cash available for distribution nor adjusted book value.</li>\n<li>Taberna, says the company, contributed less than $0.01 per share per quarter to reported CAD and ABV in 2014.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2211595-buy-the-dip-in-rait-financial-says-ladenburg\" target=\"_blank\">Buy the dip in RAIT Financial, says Ladenburg</a> (Jan. 8)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2207495-rait-financial-tumbles-sa-author-takes-note-of-sec-action\" target=\"_blank\">RAIT Financial tumbles; SA author takes note of SEC action</a> (Jan. 6)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212525\" data-linked=\"RAIT Financial: Taberna exit not material to dividends or book\" data-tweet=\"$RASF - RAIT Financial: Taberna exit not material to dividends or book https://seekingalpha.com/news/2212525-rait-financial-taberna-exit-not-material-to-dividends-or-book?source=tweet\" data-url=\"https://seekingalpha.com/news/2212525-rait-financial-taberna-exit-not-material-to-dividends-or-book\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212515\" data-ts=\"1420731990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWA\" target=\"_blank\">MWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212515-mueller-higher-following-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mueller higher following upgrade</a></h4><ul>\n<li>Mueller Water Products (<a href=\"https://seekingalpha.com/symbol/MWA\" title=\"Mueller Water Products, Inc.\">MWA</a> <font color=\"green\">+5.4%</font>) is soaring after being <a href=\"http://www.benzinga.com/news/15/01/5129734/cowen-amp-company-upgrades-mueller-water-products-to-outperform-raises-pt-to-12-5\" target=\"_blank\">upgraded</a> by Cowen from Market Perform to Outperform.</li>\n<li>The research firm has raised the PT on the stock to $12.50.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212515\" data-linked=\"Mueller higher following upgrade\" data-tweet=\"$MWA - Mueller higher following upgrade https://seekingalpha.com/news/2212515-mueller-higher-following-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2212515-mueller-higher-following-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212435\" data-ts=\"1420730429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212435-quebec-talking-with-cliffs-natural-about-re-opening-bloom-lake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quebec talking with Cliffs Natural about re-opening Bloom Lake</a></h4><ul>     <li>Shares of Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"green\">+3.9%</font>) are volatile in early trading as reports say the Quebec government is talking to the miner about <a href=\"http://www.bloomberg.com/news/2015-01-08/quebec-says-it-s-talking-to-cliffs-about-reopening-mine.html\" target=\"_blank\">re-opening the Bloom Lake iron ore mine</a>.</li>     <li>Investissement Quebec, an investment arm of Quebec's provincial government, is talking with CLF to look for the best way to relaunch Bloom Lake, Quebec's Energy and Natural Resources Minister says.</li>\n<li>CLF announced <a href=\"https://seekingalpha.com/news/2202165-cliffs-natural-pops-as-iron-ore-rebound-continues\" target=\"_blank\">last week</a> that it had ended production at Bloom Lake, as it seeks to exit higher-cost operations amid slumping iron ore prices and weakening demand in China.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212435\" data-linked=\"Quebec talking with Cliffs Natural about re-opening Bloom Lake\" data-tweet=\"$CLF - Quebec talking with Cliffs Natural about re-opening Bloom Lake https://seekingalpha.com/news/2212435-quebec-talking-with-cliffs-natural-about-re-opening-bloom-lake?source=tweet\" data-url=\"https://seekingalpha.com/news/2212435-quebec-talking-with-cliffs-natural-about-re-opening-bloom-lake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212405\" data-ts=\"1420729995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212405-yandex-qiwi-mts-jump-as-russian-markets-ruble-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex, Qiwi, MTS jump as Russian markets, ruble bounce</a></h4><ul><li>Russia' MICEX Index is <font color='green'>up 5.2%</font>, joining many <a href=\"https://seekingalpha.com/news/2211245-european-stocks-follow-asia-higher\" target=\"_blank\">European indices</a> in rallying. The ruble, meanwhile, has risen 3.9% against the dollar; the exchange rate is currently at 60.48.</li><li>Yandex (<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+7.3%</font>), Qiwi (<a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+7.1%</font>), and MTS (<a href='https://seekingalpha.com/symbol/MBT' title='Mobile TeleSystems'>MBT</a> <font color='green'>+8%</font>) have shot higher in response. Yandex, less than $4 above a 52-week low of $15.03, currently goes for 22x 2015E EPS at current exchange rates. Its 2015 revenue growth consensus (in rubles) is at 20.5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"2212405\" data-linked=\"Yandex, Qiwi, MTS jump as Russian markets, ruble bounce\" data-tweet=\"$YNDX $YNDX $QIWI - Yandex, Qiwi, MTS jump as Russian markets, ruble bounce https://seekingalpha.com/news/2212405-yandex-qiwi-mts-jump-as-russian-markets-ruble-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/2212405-yandex-qiwi-mts-jump-as-russian-markets-ruble-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212345\" data-ts=\"1420729262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212345-beer-stocks-strong-with-u-s-volume-improving\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beer stocks strong with U.S. volume improving</a></h4><ul> <li>Beer stocks are getting some early run after Constellation Brands (<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a> <font color=\"green\">+4.8%</font>) reports strong volume numbers for <a href=\"https://seekingalpha.com/news/2211875-beer-sales-lift-constellation-brands-in-fq3\" target=\"_blank\">Q4</a>.</li> <li>The company sells Corona Extra, Corona Light, Modelo Especial, Negra Modelo, and Pacifico in the U.S.</li>\n<li>Channel checks in the industry have tipped off an improvement in demand for the U.S. late in Q4.</li> <li>Gainers: Anheuser-Busch InBev (NYSE:<a href=\"https://seekingalpha.com/symbol/BUD\" title=\"Anheuser-Busch InBev SA/NV\">BUD</a>) <font color=\"green\">+2.5%</font>, Molson Coors (NYSE:<a href=\"https://seekingalpha.com/symbol/TAP\" title=\"Molson Coors Brewing Company\">TAP</a>) <font color=\"green\">+2.4%</font>, SABMiller (<a href=\"https://seekingalpha.com/symbol/SBMRY\" title=\"SABMiller plc ADR\">OTCPK:SBMRY</a>) <font color=\"green\">+2.5%</font>, Boston Beer (NYSE:<a href=\"https://seekingalpha.com/symbol/SM\" title=\"SM Energy Company\">SM</a>) <font color=\"green\">+1.0%</font>.</li> <li>Related: <a href=\"https://seekingalpha.com/news/2208415-retail-picks-tied-to-lower-gas-prices\" target=\"_blank\">Retail picks tied to lower gas prices</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2212345\" data-linked=\"Beer stocks strong with U.S. volume improving\" data-tweet=\"$STZ $STZ $BUD - Beer stocks strong with U.S. volume improving https://seekingalpha.com/news/2212345-beer-stocks-strong-with-u-s-volume-improving?source=tweet\" data-url=\"https://seekingalpha.com/news/2212345-beer-stocks-strong-with-u-s-volume-improving\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212325\" data-ts=\"1420729178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212325-google-priceline-lower-on-stifel-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google, Priceline lower on Stifel downgrades</a></h4><ul>\n<li>Believing \"the best days for shares may be behind it,\" Stifel's Scott Devitt <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130188/stifel-downgrades-google-says-best-days-for-shares-may-b\" target=\"_blank\">has downgraded</a> Google (<a href=\"https://seekingalpha.com/symbol/GOOG\" title=\"Alphabet, Inc. Cl C\">GOOG</a> <font color=\"red\">-1.4%</font>) to Hold. \"Google is in the early to mid stages of a core business maturation. The company continues to find growth outside of search, but in structurally lower-margin business [segments] such as Google Play and YouTube.\"</li>\n<li>Devitt adds Google will face stiff competition as it further expands into vertical search categories such as travel, local, and e-commerce - some of those efforts have been <a href=\"https://seekingalpha.com/news/1476091-googles-shopping-ads-gain-traction-amid-mindshare-battle-with-amazon\" target=\"_blank\">faring well</a> - and echoes <a href=\"https://seekingalpha.com/news/2181775-google-makes-new-52-week-lows-following-jpmorgan-target-cut\" target=\"_blank\">other analysts</a> in arguing Facebook's growing share of digital ad spend poses a threat.</li>\n<li>Devitt has <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130334/update-stifel-downgrades-priceline-on-headwinds-in-2015\" target=\"_blank\">also downgraded</a> Priceline (PCLN <font color=\"red\">-1.3%</font>) to Hold, citing concerns about forex  - the impact of a weak euro is already well-known - high marketing spend, and growing competition. \"The online travel market continues to benefit from secular tailwinds such as mobile adoption, but we believe that shifts in the competitive landscape and macro headwinds warrant a moderate 2015 outlook.\"</li>\n<li>TripAdvisor (<a href=\"https://seekingalpha.com/symbol/TRIP\" title=\"TripAdvisor Inc.\">TRIP</a> <font color=\"green\">+0.4%</font>) has been <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/01/5130393/update-stifel-downgrades-tripadvisor-on-lack-of-visibili\" target=\"_blank\">cut to Hold</a> due to worries about delayed booking service launches and higher marketing spend, as well as growth concerns about TripAdvisor's core metasearch service (<a href=\"https://seekingalpha.com/news/2095745-tripadvisor-minus-12_3-percent-on-eps-miss-guidance-cut\" target=\"_blank\">previous</a>).</li>\n<li>Google, Priceline and TripAdvisor were already fairly close to their 52-week lows going into today. Google and Priceline both now trade for 17x 2015E EPS. Their 2015 revenue growth consensus estimates are respectively at 19% and 17%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212325\" data-linked=\"Google, Priceline lower on Stifel downgrades\" data-tweet=\"$GOOG $GOOG $BKNG - Google, Priceline lower on Stifel downgrades https://seekingalpha.com/news/2212325-google-priceline-lower-on-stifel-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/2212325-google-priceline-lower-on-stifel-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212305\" data-ts=\"1420728860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AETUF\" target=\"_blank\">AETUF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212305-arc-resources-is-the-latest-canadian-oil-producer-to-cut-budget\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARC Resources is the latest Canadian oil producer to cut budget</a></h4><ul>     <li>ARC Resources (<a href=\"https://seekingalpha.com/symbol/AETUF\" title=\"Arc Resources Ltd.\">OTCPK:AETUF</a> <font color=\"red\">-3.9%</font>) <a href=\"http://www.arcresources.com/media/news-and-archives/135103/\" target=\"_blank\">cuts its 2015 capital budget</a> to C$750M from its previously  announced C$875M budget and C$915M it expected to spend in 2014, joining other Canadian energy producers in tightening budgets to cope with plunging oil prices.</li>     <li>Even with the capex cuts, ARC says it expects to produce ~122.5K boe/day this year, up from 115.5K boe/day through 2014's first three quarters.</li>     <li>But defying the weak sentiment around energy, ARC also says it plans to raise ~C$350M through the sale of 15.5M shares at C$22.55 each.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212305\" data-linked=\"ARC Resources is the latest Canadian oil producer to cut budget\" data-tweet=\"$AETUF - ARC Resources is the latest Canadian oil producer to cut budget https://seekingalpha.com/news/2212305-arc-resources-is-the-latest-canadian-oil-producer-to-cut-budget?source=tweet\" data-url=\"https://seekingalpha.com/news/2212305-arc-resources-is-the-latest-canadian-oil-producer-to-cut-budget\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212285\" data-ts=\"1420728695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212285-e-trade-boosted-by-deutsche-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*Trade boosted by Deutsche upgrade</a></h4><ul><li>E*Trade (<a href=\"https://seekingalpha.com/symbol/ETFC\" title=\"E*TRADE Financial Corporation\">ETFC</a> <font color=\"green\">+3.1%</font>) is an outlier to the upside among the online brokers after Deutsche Bank <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+E%2ATRADE+%28ETFC%29+to+Buy/10148680.html\" target=\"_blank\">upgrades to Buy</a> with $26 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"2212285\" data-linked=\"E*Trade boosted by Deutsche upgrade\" data-tweet=\"$ETFC - E*Trade boosted by Deutsche upgrade https://seekingalpha.com/news/2212285-e-trade-boosted-by-deutsche-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2212285-e-trade-boosted-by-deutsche-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212275\" data-ts=\"1420728648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212275-cytrx-up-on-interim-trial-results-for-ks-in-hiv-patients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx up on interim trial results for KS in HIV patients</a></h4><ul>\n<li>CytRx (<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a> <font color=\"green\">+8.6%</font>) jumps out of the gate this morning on high volume in response to its announcement of positive interim results in a Phase 2 study evaluating the safety and efficacy of <a href=\"http://www.cytrx.com/aldoxorubicin\" target=\"_blank\">aldoxorubicin </a>for the treatment of <a href=\"http://en.wikipedia.org/wiki/Kaposi%27s_sarcoma\" target=\"_blank\">Kaposi's Sarcoma</a> (KS) in HIV-positive patients.</li>\n<li>In a group of nine patients, all exhibited a decrease in skin lesions and in the number of cancer cells expressing KS virus DNA. Of the six patients with lung tumors, four demonstrated either a partial or complete response with none showing progression.</li>\n<li>Two patients experienced a grade 4 adverse event (transient <a href=\"http://www.mayoclinic.org/symptoms/neutropenia/basics/definition/sym-20050854\" target=\"_blank\">neutropenia</a> and anemia).</li>\n<li>Assuming a positive outcome of the trial, the company intends to discuss a pathway with the FDA for the approval of aldoxorubicin for this indication.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212275\" data-linked=\"CytRx up on interim trial results for KS in HIV patients\" data-tweet=\"$CYTR - CytRx up on interim trial results for KS in HIV patients https://seekingalpha.com/news/2212275-cytrx-up-on-interim-trial-results-for-ks-in-hiv-patients?source=tweet\" data-url=\"https://seekingalpha.com/news/2212275-cytrx-up-on-interim-trial-results-for-ks-in-hiv-patients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212225\" data-ts=\"1420727626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJJD\" target=\"_blank\">CJJD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212225-china-jo-jo-up-on-planned-launch-of-online-payment-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Jo-Jo up on planned launch of online payment service</a></h4><ul>\n<li>China Jo-Jo Drugstores (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CJJD\" title=\"China Jo - Jo Drugstores, Inc.\">CJJD</a>) jumps <font color=\"green\">31%</font> premarket on high volume in response to its announcement that it signed a service agreement with Alipay (China) Internet Technology Ltd. to launch an online payment service for its customers.</li>\n<li>Alipay is the dominant third party online payment provider in China with over 300M registered users and over 200 partnering financial institutions. It processes ~50% of China's e-commerce transactions.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212225\" data-linked=\"China Jo-Jo up on planned launch of online payment service\" data-tweet=\"$CJJD - China Jo-Jo up on planned launch of online payment service https://seekingalpha.com/news/2212225-china-jo-jo-up-on-planned-launch-of-online-payment-service?source=tweet\" data-url=\"https://seekingalpha.com/news/2212225-china-jo-jo-up-on-planned-launch-of-online-payment-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212165\" data-ts=\"1420727147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212165-infinity-pharma-drops-after-phase-2-fails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharma drops after Phase 2 fails</a></h4><ul>\n<li>Infinity Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a>) is off <font color=\"red\">12%</font> premarket on high volume in response to its report that a Phase 2 trial assessing duvelisib for the treatment of patients with moderate-to-severe rheumatoid arthritis (RA) failed to achieve its primary endpoint of <a href=\"http://www.arthritisselfmanagement.com/condition/definition/acr-score/\" target=\"_blank\">ACR20 </a>at Week 12.</li>\n<li>The company will cease development of any of its <a href=\"http://www.infi.com/research-development/pi3k/\" target=\"_blank\">PI3K inhibitors</a> in RA and will concentrate its efforts in blood cancers.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212165\" data-linked=\"Infinity Pharma drops after Phase 2 fails\" data-tweet=\"$INFI - Infinity Pharma drops after Phase 2 fails https://seekingalpha.com/news/2212165-infinity-pharma-drops-after-phase-2-fails?source=tweet\" data-url=\"https://seekingalpha.com/news/2212165-infinity-pharma-drops-after-phase-2-fails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212155\" data-ts=\"1420727112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBBN\" target=\"_blank\">RBBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212155-sonus-minus-3_1-percent-on-q4-revenue-forecast-acquisition-announced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonus -3.1% on Q4 revenue forecast; acquisition announced</a></h4><ul>\n<li>Sonus (SONS) expects Q4 revenue of $77M, towards the low end of a $76M-$82M guidance range and below a $79.8M consensus. EPS is expected to be at $0.03, in-line with prior guidance and consensus.</li>\n<li>The company says there was \"limited-to-no budget flush from our service provider customers\" in Q4, as previously feared. Shares <a href=\"https://seekingalpha.com/news/2210465-jnpr-sons-infn-rally-following-procera-cyan-pre-announcements\" target=\"_blank\">rose yesterday</a> after Procera and Cyan's pre-announcement stoked hopes for a strong Q4.</li>\n<li>Sonus also announces: 1) A 1:5 reverse split will go into effect on Jan. 30, after being approved by shareholders last month. 2) It has bought the software-defined networking (SDN) tech assets of startup Treq Labs for $10.1M.</li>\n<li>Treq's offerings for the <a href=\"https://www.sdxcentral.com/resources/sdncentral-library-sdn-market-report/infographic-sdn-market-to-reach-35b-by-2018/\" target=\"_blank\">budding</a> SDN market are focused on VoIP, IP video, and unified communications traffic (areas Sonus is quite familiar with), allowing enterprises to priority latency-sensitive traffic and quickly provision network services on an app-by-app basis.</li>\n<li>Sonus will pay an earn-out of 6.6M shares through 2017, if the SDN business produces at least $60M in revenue during that period. An 11M-share earn-out will be paid if $150M in revenue is produced.</li>\n<li>Full Q4 results are due on Feb. 18.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212155\" data-linked=\"Sonus -3.1% on Q4 revenue forecast; acquisition announced\" data-tweet=\"$RBBN - Sonus -3.1% on Q4 revenue forecast; acquisition announced https://seekingalpha.com/news/2212155-sonus-minus-3_1-percent-on-q4-revenue-forecast-acquisition-announced?source=tweet\" data-url=\"https://seekingalpha.com/news/2212155-sonus-minus-3_1-percent-on-q4-revenue-forecast-acquisition-announced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212145\" data-ts=\"1420726965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGM\" target=\"_blank\">MGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212145-las-vegas-the-story-with-mgm-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Las Vegas the story with MGM Resorts</a></h4><ul> <li>Wells Fargo <a href=\"http://www.analystratings.net/stocks/NYSE/MGM/\" target=\"_blank\">upgrades</a> MGM Resorts (NYSE:<a href=\"https://seekingalpha.com/symbol/MGM\" title=\"MGM Resorts International\">MGM</a>) to Outperform from Market Perform after watching shares peel off 6.8% in a month.</li> <li>The investment firm points to stronger trends in Las Vegas.</li> <li>Not just a Macau story: MGM took in $1.578B in revenue from U.S. casinos in Q3, compared to $794K from China properties.</li> <li>MGM <font color=\"green\">+1.8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212145\" data-linked=\"Las Vegas the story with MGM Resorts\" data-tweet=\"$MGM - Las Vegas the story with MGM Resorts https://seekingalpha.com/news/2212145-las-vegas-the-story-with-mgm-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/2212145-las-vegas-the-story-with-mgm-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212125\" data-ts=\"1420726533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212125-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/BIND\" title=\"BIND Therapeutics, Inc.\">BIND</a> <font color=\"green\">+43%</font>. <a href=\"https://seekingalpha.com/symbol/CJJD\" title=\"China Jo - Jo Drugstores, Inc.\">CJJD</a> <font color=\"green\">+39%</font>. BIOD <font color=\"green\">+36%</font>. <a href=\"https://seekingalpha.com/symbol/NBIX\" title=\"Neurocrine Biosciences, Inc.\">NBIX</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/CYRN\" title=\"CYREN Ltd.\">CYRN</a> <font color=\"green\">+22%</font>. NRX <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a> <font color=\"green\">+13%</font>. VLCCF <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/FOLD\" title=\"Amicus Therapeutics, Inc.\">FOLD</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/PIR\" title=\"Pier 1 Imports Inc.\">PIR</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CONN\" title=\"Conn's, Inc.\">CONN</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/GST\" title=\"Gastar Exploration Inc.\">GST</a> <font color=\"green\">+7%</font>. PBR-A <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/MEET\" title=\"The Meet Group, Inc.\">MEET</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CRK\" title=\"Comstock Resources Inc.\">CRK</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/MBT\" title=\"Mobile TeleSystems\">MBT</a> <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/STML\" title=\"Stemline Therapeutics\">STML</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SIG\" title=\"Signet Jewelers Limited\">SIG</a> <font color=\"red\">-7%</font>. NBG <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212125\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$BIND $CJJD $ALBO - Premarket Gainers / Losers https://seekingalpha.com/news/2212125-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2212125-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212115\" data-ts=\"1420726447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212115-dryships-grabs-ocean-rig-contract-extension-with-eni\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips grabs Ocean Rig contract extension with Eni</a></h4><ul>\n<li>DryShips (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DRYS\" title=\"DryShips Inc.\">DRYS</a>) <font color=\"green\">+3.9%</font> premarket on news that its Ocean Rig UDW (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ORIG\" title=\"Ocean Rig UDW Inc.\">ORIG</a>) subsidiary has secured a contract extension for one of its drillships  with Eni (NYSE:<a href=\"https://seekingalpha.com/symbol/E\" title=\"ENI S.p.A.\">E</a>) and gains work for possibly  another two units.</li>\n<li>As part of the contract extension for the Ocean Rig Poseidon, ORIG will adjust the existing dayrate of the Ocean Rig Poseidon  contract and Eni will enter into two contracts for  the employment of one or more of ORIG's available drillships in West  Africa starting in Q1.</li>\n<li>DRYS says the agreement increases ORIG's total contract backlog by ~$187M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212115\" data-linked=\"DryShips grabs Ocean Rig contract extension with Eni\" data-tweet=\"$DRYS $DRYS $ORIG - DryShips grabs Ocean Rig contract extension with Eni https://seekingalpha.com/news/2212115-dryships-grabs-ocean-rig-contract-extension-with-eni?source=tweet\" data-url=\"https://seekingalpha.com/news/2212115-dryships-grabs-ocean-rig-contract-extension-with-eni\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212065\" data-ts=\"1420725929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212065-barnes-and-noble-higher-after-updating-on-holiday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble higher after updating on holiday sales</a></h4><ul> <li>Barnes &amp; Noble (NYSE:<a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a>) reports core comparable-bookstore sales rose 1.7% during the nine-week holiday period.</li> <li>Total retail sales +0.2% to $1.1B.</li> <li>Nook sales -55.4% to $56M on a huge slide (expected) in device sales.</li> <li>Based on the results, B&amp;N expects full-year core comparable-store sales to be flat and EBITDA losses in the Nook segment to decline compared to last year.</li> <li>BKS <font color=\"green\">+4.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2212065\" data-linked=\"Barnes &amp; Noble higher after updating on holiday sales\" data-tweet=\"$BKS - Barnes &amp; Noble higher after updating on holiday sales https://seekingalpha.com/news/2212065-barnes-and-noble-higher-after-updating-on-holiday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/2212065-barnes-and-noble-higher-after-updating-on-holiday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212025\" data-ts=\"1420725591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212025-neurocrine-bio-up-on-positive-phase-3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine Bio up on positive Phase 3 results</a></h4><ul>\n<li>Neurocrine Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NBIX\" title=\"Neurocrine Biosciences, Inc.\">NBIX</a>) jumps <font color=\"green\">25%</font> premarket on higher-than-normal volume in response to collaboration partner AbbVie's (NYSE:<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a>) <a href=\"http://abbvie.mediaroom.com/2015-01-08-AbbVie-Announces-Positive-Top-Line-Results-From-Phase-3-Study-of-Investigational-Medicine-Elagolix-in-Patients-with-Endometriosis\" target=\"_blank\">announcement </a>of positive top-line results in a Phase 3 trial assessing the safety and efficacy of <a href=\"http://www.neurocrine.com/index.cfm?navId=23\" target=\"_blank\">elagolix </a>in premenopausal women with endometriosis. The study met its co-primary endpoints (p&lt;0.001) of reducing scores of non-menstrual pelvic pain (NMPP) and menstrual pain associated with endometriosis at Month 3 as measured by the Daily Assessment of Endometriosis Pain scale.</li>\n<li>Patients in the trial will continue in either post-treatment follow-up or a blinded six-month extension study. AbbVie plans to present the results at a future medical conference.</li>\n<li>Neurocrine Bio and AbbVie entered into an exclusive worldwide collaboration agreement to commercialize elagolix in June 2010.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212025\" data-linked=\"Neurocrine Bio up on positive Phase 3 results\" data-tweet=\"$NBIX $NBIX $ABBV - Neurocrine Bio up on positive Phase 3 results https://seekingalpha.com/news/2212025-neurocrine-bio-up-on-positive-phase-3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/2212025-neurocrine-bio-up-on-positive-phase-3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212015\" data-ts=\"1420725471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAN\" target=\"_blank\">SAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212015-santander-to-raise-nearly-9b-in-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Santander to raise nearly $9B in share sale</a></h4><ul>\n<li>The<a href=\"http://www.bloomberg.com/news/2015-01-08/santander-said-to-consider-multi-billion-euro-capital-increase.html\" target=\"_blank\"> sale will run through</a> an \"accelerated process\" reports Bloomberg, citing a regulatory filing, meaning it's probably happening tonight. There's no word yet available on what Santander (NYSE:<a href=\"https://seekingalpha.com/symbol/SAN\" title=\"Banco Santander S.A.\">SAN</a>) is planning on doing with its dividend, but surely there will be a change in policy on that.</li>\n<li>Shares<font color=\"red\"> -2.5%</font> premarket</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2211795-santander-halted-as-capital-raise-plan-reportedly-on-tap\" target=\"_blank\">Santander halted as capital raise plan reportedly on tap</a> (Jan. 8)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212015\" data-linked=\"Santander to raise nearly $9B in share sale\" data-tweet=\"$SAN - Santander to raise nearly $9B in share sale https://seekingalpha.com/news/2212015-santander-to-raise-nearly-9b-in-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/2212015-santander-to-raise-nearly-9b-in-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2212005\" data-ts=\"1420725043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGL\" target=\"_blank\">GOGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2212005-knightsbridge-inks-15-long-term-capesize-contracts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knightsbridge inks 15 long-term capesize contracts</a></h4><ul>     <li>Knightsbridge Shipping (VLCCF) <font color=\"green\">+14.5%</font> premarket after signing a deal for the long-term charter of 15 capesizes to RWE Supply &amp; Trading.</li>     <li>The contracts with an average length of around five years are index linked to the Baltic Capesize 4T/C Index plus a pre-agreed premium.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2212005\" data-linked=\"Knightsbridge inks 15 long-term capesize contracts\" data-tweet=\"$GOGL - Knightsbridge inks 15 long-term capesize contracts https://seekingalpha.com/news/2212005-knightsbridge-inks-15-long-term-capesize-contracts?source=tweet\" data-url=\"https://seekingalpha.com/news/2212005-knightsbridge-inks-15-long-term-capesize-contracts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211975\" data-ts=\"1420724634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFSI\" target=\"_blank\">AFSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211975-amtrust-lower-by-4_4-percent-as-secondary-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmTrust lower by 4.4% as secondary prices</a></h4><ul>\n<li>Pricing isn't detailed, but AmTrust (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AFSI\" title=\"AmTrust Financial Services, Inc.\">AFSI</a>) will receive about $150M in net proceeds from the 3M share sale, with the underwriters still having an option to buy another 450K shares at the offering price.</li>\n<li>Shares <font color=\"red\">-4.35%</font> to $51.65 premarket</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2210795-amtrust-financial-launches-3m-share-secondary\" target=\"_blank\">AmTrust Financial launches 3M share secondary</a> (Jan. 7)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211975\" data-linked=\"AmTrust lower by 4.4% as secondary prices\" data-tweet=\"$AFSI - AmTrust lower by 4.4% as secondary prices https://seekingalpha.com/news/2211975-amtrust-lower-by-4_4-percent-as-secondary-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/2211975-amtrust-lower-by-4_4-percent-as-secondary-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211855\" data-ts=\"1420723039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211855-holiday-retail-comps-plus-4-percent-at-urban-outfitters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Holiday retail comps +4% at Urban Outfitters</a></h4><ul> <li>Urban Outfitters (NASDAQ:<a href=\"https://seekingalpha.com/symbol/URBN\" title=\"Urban Outfitters, Inc.\">URBN</a>) reports comparable-store sales rose 4% during the two-month holiday period.</li> <li>Total sales were up 10% to $785M.</li> <li>Comp growth by brand: Free People +17%; Anthropologie +5%; Urban Outfitters +1%.</li> <li>The company's wholesales segment struck a 14% sales gain for the period.</li> <li>URBN <font color=\"green\">+4.6%</font> premarket (light volume).</li> </ul><div class=\"tiny-share-widget\" data-id=\"2211855\" data-linked=\"Holiday retail comps +4% at Urban Outfitters\" data-tweet=\"$URBN - Holiday retail comps +4% at Urban Outfitters https://seekingalpha.com/news/2211855-holiday-retail-comps-plus-4-percent-at-urban-outfitters?source=tweet\" data-url=\"https://seekingalpha.com/news/2211855-holiday-retail-comps-plus-4-percent-at-urban-outfitters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211845\" data-ts=\"1420722654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARO\" target=\"_blank\">ARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211845-comps-down-but-margins-up-at-aeropostale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comps down but margins up at Aeropostale</a></h4><ul> <li>Aeropostale (NYSE:<a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a>) announces comparable-store sales fell 9% during the 9-week holiday season.</li> <li>The mark sticks out with several other mall retailers reporting a gain over last year, although Aeropostale notes it held back on promotional activity.</li> <li>Total sales -11% to $507.8M.</li> <li>The company says it achieved higher margins than expected over the period - leading to a lift in guidance for a smaller loss for FQ4.</li> <li>Full results will be released on March 12.</li> <li>ARO <font color=\"green\">+4.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2211845\" data-linked=\"Comps down but margins up at Aeropostale\" data-tweet=\"$ARO - Comps down but margins up at Aeropostale https://seekingalpha.com/news/2211845-comps-down-but-margins-up-at-aeropostale?source=tweet\" data-url=\"https://seekingalpha.com/news/2211845-comps-down-but-margins-up-at-aeropostale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211755\" data-ts=\"1420722230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOL\" target=\"_blank\">APOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211755-more-on-apollo-groups-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Apollo Group&#39;s FQ1</a></h4><ul>\n<li>Apollo Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APOL\" title=\"Apollo Education Group, Inc.\">APOL</a>) reports University of Phoenix degreed enrollment fell 13.5% to 227.4K in FQ1.</li>\n<li>New degreed enrollment was 5.0% lower than a year ago at 39,600.</li>\n<li>Segment revenue: University of Phoenix: $592.85M (-20.41%); Apollo Global: $114.14M (26.31%); Other: $11.06M (-8.80%).</li>\n<li>Segment operating income: University of Phoenix: $93.51M (-49.03%); Apollo Global: -$4.84M; Other: -$28.18M.</li>\n<li>\n<b>FQ2 Guidance</b>: Net revenue: $580M to $595M; Operating loss: $25M to $35M.</li>\n<li>\n<b>FY2015 Guidance</b>: Net revenue: $2.74B to $2.80B; Operating income: $250M to $290M.</li>\n<li>APOL <font color=\"red\">-5.84%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211755\" data-linked=\"More on Apollo Group&#39;s FQ1\" data-tweet=\"$APOL - More on Apollo Group&#39;s FQ1 https://seekingalpha.com/news/2211755-more-on-apollo-groups-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/2211755-more-on-apollo-groups-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211785\" data-ts=\"1420722140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRXGQ\" target=\"_blank\">NRXGQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211785-nephrogenex-up-on-positive-feedback-from-ema-on-pyridorin-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NephroGenex up on positive feedback from EMA on Pyridorin trial</a></h4><ul>\n<li>Nano cap NephroGenex (NRX) is up <font color=\"green\">16%</font> premarket on higher-than-normal volume in response to its report that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding its Phase 3 program evaluating <a href=\"http://www.nephrogenex.com/product-candidates/pyridorin/\" target=\"_blank\">Pyridorin </a>(pyridoxamine dihydrochloride) in diabetic nephropathy.</li>\n<li>The EMA indicated that the current Phase 3 design could be adequate to support a Marketing Authorization Application (MAA) for full approval in Europe.</li>\n<li>The FDA also accepted the Phase 3 design under a Special Protocol Assessment.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2201085-nephrogenex-up-big-on-pyridorin-safety-study\" target=\"_blank\">NephroGenex up big on Pyridorin safety study</a> (Dec. 31, 2014)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211785\" data-linked=\"NephroGenex up on positive feedback from EMA on Pyridorin trial\" data-tweet=\"$NRXGQ - NephroGenex up on positive feedback from EMA on Pyridorin trial https://seekingalpha.com/news/2211785-nephrogenex-up-on-positive-feedback-from-ema-on-pyridorin-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/2211785-nephrogenex-up-on-positive-feedback-from-ema-on-pyridorin-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211725\" data-ts=\"1420721418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIND\" target=\"_blank\">BIND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211725-bind-therapeutics-up-big-premarket-on-lead-product-update-and-strategic-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bind Therapeutics up big premarket on lead product update and strategic outlook</a></h4><ul>\n<li>Thinly-traded nano cap Bind Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIND\" title=\"BIND Therapeutics, Inc.\">BIND</a>) is up <font color=\"green\">55%</font> premarket on higher-than-normal volume in response to its update on Bind-014 and outlook for this year.</li>\n<li>Patient enrollment is underway in a global two-tiered 80-subject Phase 2 trial evaluating <a href=\"http://www.bindtherapeutics.com/pipeline/BIND014.html\" target=\"_blank\">Bind-014</a> (PSMA-targeted <a href=\"http://en.wikipedia.org/wiki/Docetaxel\" target=\"_blank\">docetaxel</a>) in patients with <a href=\"http://en.wikipedia.org/wiki/KRAS\" target=\"_blank\">KRAS </a>mutation-positive non-small cell lung cancer (NSCLC) and squamous NSCLC. Investigators expect preliminary data as early as the second of half of this year for the KRAS study (40 patients) and late 2015 for the squamous study (40 patients).</li>\n<li>The company is initiating a two-stage multi-tumor Phase 2 trial assessing Bind-014 in patients with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000291.htm\" target=\"_blank\">cholangiocarinoma</a>, cervical cancer, bladder cancer and head and neck cancers. The first patients will be enrolled in Q2. The data readout for Stage 1 is expected in early 2016.</li>\n<li>Top-line results for a 42-patient Phase 2 trial evaluating Bind-014 in metastatic castration resistant prostate cancer (mCRPC) showed median radiographic progression-free survival (rPFS) of 8.1 months. 24 patients continue to be followed for overall survival (OS).</li>\n<li>It expects one of its collaborators, Merck, Pfizer or AstraZeneca, to file an IND by mid-year for an <a href=\"http://www.bindtherapeutics.com/technology/accurins.html\" target=\"_blank\">Accurin </a>Therapeutic which will trigger a milestone payment to Bind.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211725\" data-linked=\"Bind Therapeutics up big premarket on lead product update and strategic outlook\" data-tweet=\"$BIND - Bind Therapeutics up big premarket on lead product update and strategic outlook https://seekingalpha.com/news/2211725-bind-therapeutics-up-big-premarket-on-lead-product-update-and-strategic-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/2211725-bind-therapeutics-up-big-premarket-on-lead-product-update-and-strategic-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211635\" data-ts=\"1420720941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211635-more-on-global-payments-fq2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Global Payments&#39; FQ2</a></h4><ul>\n<li>Global Payments (NYSE:<a href=\"https://seekingalpha.com/symbol/GPN\" title=\"Global Payments Inc.\">GPN</a>) reports a 9.34% rise in North America merchant services revenue to $488.78M.</li>\n<li>International merchant services grew 11.45% to $208.52M.</li>\n<li>Segment Cash earnings : North America merchant services: $85.42M (+10.05%); International merchant services: $83.53M (+19.60%).</li>\n<li>\n<b>FY2015 Guidance</b>: Total revenue: $2.75B to $2.80B (+8% to +10%); Cash EPS: $4.75 to $4.83 (+15% to 17%); GAAP diluted EPS: $3.99 to $4.07 (+18% to +21%).</li>\n<li>FQ2 results</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211635\" data-linked=\"More on Global Payments&#39; FQ2\" data-tweet=\"$GPN - More on Global Payments&#39; FQ2 https://seekingalpha.com/news/2211635-more-on-global-payments-fq2?source=tweet\" data-url=\"https://seekingalpha.com/news/2211635-more-on-global-payments-fq2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211575\" data-ts=\"1420719793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211575-futures-surge-higher-as-globe-rallies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures surge higher as globe rallies</a></h4><ul>\n<li>With the small losing streak in the stock market broken, investors get back to buying low and selling high. U.S. stock index futures are all ahead by <font color=\"green\">more than 1%</font> as Europe <font color=\"green\">rallies about 2%</font>, and the Nikkei closes <font color=\"green\">higher by 1.7%</font>.</li>\n<li>Shanghai naturally goes its own way and <font color=\"red\">shed 2.4%</font> overnight.</li>\n<li>Tomorrow brings the December jobs report at 8:30 ET.</li>\n<li>The 10-year Treasury yield is up three basis points to 1.99% and gold is down $4 per ounce to $1,206. Oil is flat at $48.91 per barrel.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/sh\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/sso\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/sds\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/voo\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/psq\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/ivv\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/spxu\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/upro\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/tqqq\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/spxl\" title=\"Direxion Daily S&amp;P 500 Bull 3X Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/rsp\" title=\"Guggenheim S&amp;P Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/qid\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/sqqq\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/dog\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/qld\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/dxd\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/rwl\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/eps\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/udow\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/sdow\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/ddm\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/bxub\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/qqew\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/qqqe\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/splx\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/bxuc\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/sfla\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/qqxt\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/spuu\" title=\"Direxion Daily S&amp;P 500 Bull 2X Shares ETF\">SPUU</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211575\" data-linked=\"Futures surge higher as globe rallies\" data-tweet=\"$SPY $QQQ $DIA - Futures surge higher as globe rallies https://seekingalpha.com/news/2211575-futures-surge-higher-as-globe-rallies?source=tweet\" data-url=\"https://seekingalpha.com/news/2211575-futures-surge-higher-as-globe-rallies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211565\" data-ts=\"1420719694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDO\" target=\"_blank\">FDO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211565-margins-contract-at-family-dollar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins contract at Family Dollar</a></h4><ul> <li>Family Dollar (NYSE:<a href=\"https://seekingalpha.com/symbol/FDO\" title=\"Family Dollar Stores Inc.\">FDO</a>) reports comparable-store sales fell 0.4% in FQ1 as the retailer shifted to an \"everyday\" pricing strategy.</li> <li>Gross profit rate -90 bps to 33.4% on a higher mix of food and tobacco sales impacted results.</li> <li>Operating profit -170 bps to 3.1%.</li> <li>SG&amp;A expense rate +80 bps to 30.3%.</li> <li>Merchandise inventory +4.1% to $1.71B.</li> <li>Capex spending down 8% on fewer store openings.</li> <li>FDO <font color=\"red\">-1.0%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2211565\" data-linked=\"Margins contract at Family Dollar\" data-tweet=\"$FDO - Margins contract at Family Dollar https://seekingalpha.com/news/2211565-margins-contract-at-family-dollar?source=tweet\" data-url=\"https://seekingalpha.com/news/2211565-margins-contract-at-family-dollar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2211545\" data-ts=\"1420719493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2211545-biodel-up-big-premarket-on-clinical-trial-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biodel up big premarket on clinical trial results</a></h4><ul>\n<li>Thinly-traded nano cap Biodel (BIOD) is up <font color=\"green\">41%</font> premarket on higher-than-normal volume in response to its report of positive Phase 2a results for its concentrated insulin product candidate, BIOD-531.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2210895-biodel-concentrated-insulin-beats-lillys-in-phase-2-study\" target=\"_blank\">Biodel concentrated insulin beats Lilly's in Phase 2 study</a> (Jan. 7)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2211545\" data-linked=\"Biodel up big premarket on clinical trial results\" data-tweet=\"$ALBO - Biodel up big premarket on clinical trial results https://seekingalpha.com/news/2211545-biodel-up-big-premarket-on-clinical-trial-results?source=tweet\" data-url=\"https://seekingalpha.com/news/2211545-biodel-up-big-premarket-on-clinical-trial-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}